Sempra (SRE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 GAAP earnings were $713M ($1.12/share), up from $603M ($0.95/share) in Q2 2023; adjusted Q2 2024 earnings were $567M ($0.89/share), down from $594M ($0.94/share) year-over-year.
First half 2024 GAAP earnings were $1.514B ($2.38/share) vs. $1.572B ($2.49/share) in 2023; adjusted earnings were $1.421B ($2.24/share) vs. $1.516B ($2.40/share) year-over-year.
Affirmed full-year 2024 and 2025 adjusted EPS guidance ranges, despite project delays and mixed segment results.
Strategic focus on safety, operational excellence, and capital investments in California and Texas to support decarbonization, reliability, and growth.
Segment realignment in late 2023 now groups SDG&E and SoCalGas as Sempra California, with Sempra Texas Utilities and Sempra Infrastructure as the other segments.
Financial highlights
Q2 2024 total revenues were $3.011B, down from $3.335B in Q2 2023; six-month revenues were $6.651B, down from $9.895B year-over-year.
Q2 2024 adjusted EPS was $0.89, down from $0.94 in Q2 2023; YTD-2024 adjusted EPS was $2.24, down from $2.40 YTD-2023.
Q2 2024 GAAP EPS was $1.12, up from $0.95 in Q2 2023; YTD-2024 GAAP EPS was $2.38, down from $2.49 YTD-2023.
Sempra California's Q2 earnings were $316M (down 7% YoY); Sempra Texas Utilities $202M (up 26% YoY); Sempra Infrastructure $291M (up 40% YoY).
SDG&E Q2 earnings were $186M (up 1% YoY); SoCalGas Q2 earnings were $130M (down 16% YoY).
Outlook and guidance
Affirmed 2024 adjusted EPS guidance of $4.60–$4.90 and 2025 EPS guidance of $4.90–$5.25; updated 2024 GAAP EPS guidance to $4.74–$5.04.
Long-term projected EPS growth rate remains at 6%–8%.
Expectation of higher future capital spending, especially in Texas, with updates anticipated in Q4.
Sempra expects to meet cash requirements through operations, cash, credit facilities, and financing, with adequate liquidity for both short- and long-term needs.
SDG&E and SoCalGas await a final CPUC decision on the 2024 GRC, with retroactive revenue recognition to January 1, 2024.
Latest events from Sempra
- $65B capital plan and record adjusted EPS drive sector-leading growth outlook.SRE
Q4 202526 Feb 2026 - Q3 EPS fell, but guidance and $3B equity plan reaffirmed; Texas and LNG drive growth.SRE
Q3 202416 Jan 2026 - Q1 2025 EPS up, guidance affirmed, and major asset sales and capital investment drive outlook.SRE
Q1 20258 Jan 2026 - 2024 adjusted EPS hit $4.65, with a $56B capital plan and 7–9% EPS growth targeted.SRE
Q4 20247 Jan 2026 - Board refreshment, performance-based pay, and ambitious ESG targets headline the 2025 proxy.SRE
Proxy Filing1 Dec 2025 - Director nominee Jennifer M. Kirk will become CEO of Exubrion Therapeutics in May 2025.SRE
Proxy Filing1 Dec 2025 - Virtual meeting to elect 11 directors, ratify auditor, and approve executive pay.SRE
Proxy Filing1 Dec 2025 - Q2 2025 adjusted EPS held steady as utility growth, LNG progress, and guidance advanced.SRE
Q2 202523 Nov 2025 - Adjusted EPS up, major asset sale and Texas/LNG growth drive strong long-term outlook.SRE
Q3 20255 Nov 2025